论文部分内容阅读
目的:探究分析对未足月胎膜早破患者采取期待疗法进行治疗的临床效果。方法:选取我院2011年9月-2013年9月收治的46例未足月胎膜早破患者作为临床研究对象,所有患者均采用期待疗法进行治疗,对其治疗效果进行观察。结果:治疗时间为3~15 d,分娩时,平均孕周为(35.6±1.4)周,延长(1.7±0.5)周;32例自然分娩,14例剖宫产;产妇的产后出血量为(218.3±50.4)mL;2例产妇合并感染;新生儿的平均体质量为2.98 kg;新生儿的Apgar评分为8.9分;4例新生儿呼吸窘迫综合征,2例死亡。结论:对未足月胎膜早破患者采用期待疗法进行治疗,能够提高胎儿的成活率与生存质量,降低母婴并发症,延长孕周,有效改善母婴妊娠结局。
Objective: To explore the clinical effect of expectant therapy on patients with preterm premature rupture of membranes. Methods: Forty-six patients with preterm premature rupture of membranes treated in our hospital from September 2011 to September 2013 were selected as the clinical study subjects. All patients were treated with expectant therapy, and their therapeutic effects were observed. Results: The treatment time ranged from 3 to 15 days. The mean gestational age at delivery was (35.6 ± 1.4) weeks, prolonged by 1.7 ± 0.5 weeks. 32 cases of spontaneous delivery and 14 cases of cesarean section were observed. The amount of postpartum hemorrhage was 218.3 ± 50.4) mL; 2 maternal infection; neonatal average body mass of 2.98 kg; neonatal Apgar score of 8.9 points; 4 cases of neonatal respiratory distress syndrome, and 2 deaths. Conclusion: Treatment of patients with preterm premature rupture of membranes with expectant therapy can improve fetal survival rate and quality of life, reduce maternal and infant complications, extend gestational age, and effectively improve maternal and fetal pregnancy outcomes.